-
Something wrong with this record ?
Chicken immunoglobulins for prophylaxis: Effect of inhaled antibodies on inflammatory parameters in rat airways
Jana Hadrabová, Barbora Majerová, Věra Černá, Michaela Moserová, Radim Holuša, Václav Mandys, Marie Stiborová, Ilja Stříž, Petr Hodek
Language English Country Czech Republic
Document type Research Support, Non-U.S. Gov't
- MeSH
- Administration, Inhalation * MeSH
- Bronchoalveolar Lavage MeSH
- Cystic Fibrosis * prevention & control MeSH
- Cytokines MeSH
- Immunoglobulins * MeSH
- Rats MeSH
- Models, Animal MeSH
- Antibodies MeSH
- Pseudomonas * drug effects MeSH
- Egg Yolk MeSH
- Inflammation MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
The prophylaxis against microbial airway infections of cystic fibrosis (CF) patients is an emerging application of chicken yolk antibody (IgY), however, no data on the effect of inhaled IgY have been published yet. Rats were daily (for 28 days) exposed to an aerosol of IgY, ovalbumin (OVA), Fab fragment of IgY, or PBS and their serum, bronchoalveolar lavage (BAL) and lung tissue were examined for inflammation signs. There were no marked changes in lung parenchyma, except for an elevated number of alveolar macrophages in the OVA-exposed group. While the administration of OVA or IgY aerosols slightly increased levels of cytokine TNF-α and GRO/KC in BAL fluid, a marked elevation of GM-CSF in serum was observed after the OVA inhalation. The administration of Fab induced expression of IL-1β > IL-18 in serum, in contrast no effect exerted by IgY. Our results suggest that the aerosolized IgY did not cause any deleterious effects in rat lungs.
Charles University Prague 3rd Faculty of Medicine Department of Pathology Prague
Charles University Prague Faculty of Science Department of Biochemistry Pague
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15021862
- 003
- CZ-PrNML
- 005
- 20150902135733.0
- 007
- ta
- 008
- 150626s2015 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2014.04.003 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hadrabová, Jana $7 _AN083169 $u Charles University in Prague, Faculty of Science, Department of Biochemistry, Pague 2
- 245 10
- $a Chicken immunoglobulins for prophylaxis: Effect of inhaled antibodies on inflammatory parameters in rat airways / $c Jana Hadrabová, Barbora Majerová, Věra Černá, Michaela Moserová, Radim Holuša, Václav Mandys, Marie Stiborová, Ilja Stříž, Petr Hodek
- 504 __
- $a Literatura
- 520 9_
- $a The prophylaxis against microbial airway infections of cystic fibrosis (CF) patients is an emerging application of chicken yolk antibody (IgY), however, no data on the effect of inhaled IgY have been published yet. Rats were daily (for 28 days) exposed to an aerosol of IgY, ovalbumin (OVA), Fab fragment of IgY, or PBS and their serum, bronchoalveolar lavage (BAL) and lung tissue were examined for inflammation signs. There were no marked changes in lung parenchyma, except for an elevated number of alveolar macrophages in the OVA-exposed group. While the administration of OVA or IgY aerosols slightly increased levels of cytokine TNF-α and GRO/KC in BAL fluid, a marked elevation of GM-CSF in serum was observed after the OVA inhalation. The administration of Fab induced expression of IL-1β > IL-18 in serum, in contrast no effect exerted by IgY. Our results suggest that the aerosolized IgY did not cause any deleterious effects in rat lungs.
- 650 12
- $a cystická fibróza $x prevence a kontrola $7 D003550
- 650 _2
- $a vaječný žloutek $7 D004530
- 650 _2
- $a protilátky $7 D000906
- 650 12
- $a imunoglobuliny $7 D007136
- 650 12
- $a aplikace inhalační $7 D000280
- 650 _2
- $a bronchoalveolární laváž $7 D018893
- 650 _2
- $a cytokiny $7 D016207
- 650 _2
- $a zánět $7 D007249
- 650 12
- $a Pseudomonas $x účinky léků $7 D011549
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a modely u zvířat $7 D023421
- 650 _2
- $a zvířata $7 D000818
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Majerová, Barbora $7 _AN083170 $u Charles University in Prague, Faculty of Science, Department of Biochemistry, Pague 2
- 700 1_
- $a Černá, Věra $7 xx0166973 $u Charles University in Prague, Faculty of Science, Department of Biochemistry, Pague 2
- 700 1_
- $a Moserová, Michaela $7 xx0125669 $u Charles University in Prague, Faculty of Science, Department of Biochemistry, Pague 2
- 700 1_
- $a Holuša, Radim, $d 1927- $7 xx0075628 $u National Institute of Public Health, Prague
- 700 1_
- $a Mandys, Václav, $d 1951- $7 jn20000401720 $u Charles University in Prague, 3rd Faculty of Medicine, Department of Pathology, Prague 10
- 700 1_
- $a Stiborová, Marie, $d 1950-2020 $7 jo2005259907 $u Charles University in Prague, Faculty of Science, Department of Biochemistry, Pague 2
- 700 1_
- $a Stříž, Ilja, $d 1958- $7 jn20000402309 $u Institute for Clinical and Experimental Medicine, Prague 4
- 700 1_
- $a Hodek, Petr, $d 1959- $7 jo2003186329 $u Charles University in Prague, Faculty of Science, Department of Biochemistry, Pague 2
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 13, č. 1 (2015), s. 19-22 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2015/01/03.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20150626071913 $b ABA008
- 991 __
- $a 20150902135853 $b ABA008
- 999 __
- $a ok $b bmc $g 1082260 $s 904830
- BAS __
- $a 3
- BMC __
- $a 2015 $b 13 $c 1 $d 19-22 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK137 $d 20150902 $a NLK 2015-31/vt